C K Goldman - JoVE Visualize

Showing results (41-50 of 49) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 49 results.

Transplantation|November 1, 1990

Use of yttrium-90-labeled anti-Tac antibody in primate xenograft transplantationM M Cooper, R C Robbins, C K Goldman, et al.

The Journal of Clinical Investigation|December 1, 1976

The Sézary syndrome: a malignant proliferation of helper T cellsS Broder, R L Edelson, M A Lutzner, et al.

The Journal of Clinical Investigation|June 1, 1984

Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factorT A Waldmann, W C Greene, P S Sarin, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 23, 1999

Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trialR B Nussenblatt, E Fortin, R Schiffman, et al.

The Journal of Experimental Medicine|November 1, 1984

Expression of interleukin 2 receptors on activated human B cellsT A Waldmann, C K Goldman, R J Robb, et al.

Cancer Research|September 1, 1985

Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemiaT A Waldmann, D L Longo, W J Leonard, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991

Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survivalP S Brown, G L Parenteau, F M Dirbas, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 22, 1998

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rateC K Goldman, R L Kendall, G Cabrera, et al.

Blood|December 1, 1995

Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-TacT A Waldmann, J D White, J A Carrasquillo, et al.

Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 49 results.

Transplantation|November 1, 1990

Use of yttrium-90-labeled anti-Tac antibody in primate xenograft transplantationM M Cooper, R C Robbins, C K Goldman, et al.

The Journal of Clinical Investigation|December 1, 1976

The Sézary syndrome: a malignant proliferation of helper T cellsS Broder, R L Edelson, M A Lutzner, et al.

The Journal of Clinical Investigation|June 1, 1984

Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factorT A Waldmann, W C Greene, P S Sarin, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 23, 1999

Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trialR B Nussenblatt, E Fortin, R Schiffman, et al.

The Journal of Experimental Medicine|November 1, 1984

Expression of interleukin 2 receptors on activated human B cellsT A Waldmann, C K Goldman, R J Robb, et al.

Cancer Research|September 1, 1985

Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemiaT A Waldmann, D L Longo, W J Leonard, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991

Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survivalP S Brown, G L Parenteau, F M Dirbas, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 22, 1998

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rateC K Goldman, R L Kendall, G Cabrera, et al.

Blood|December 1, 1995

Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-TacT A Waldmann, J D White, J A Carrasquillo, et al.

Pageof 5